Y-mAbs claims FDA OK for neuroblastoma drug DanyelzaY-mAbs Therapeutics has claimed its first product approval, getting a green light from the FDA for Danyelza for Share XY-mAbs claims FDA OK for neuroblastoma drug Danyelzahttps://pharmaphorum.com/news/y-mabs-claims-fda-ok-for-neuroblastoma-drug-danyelza/
